
acid. In human milk, palmitic acid is mainly in the 2
position on the triglyceride molecule, and this is
absorbed more easily than palmitic acid in the 1 and
3 positions, as found in cows’ milk.
0014 No single fat source can adequately reflect the
characteristics of the fat profile in mature breast
milk, so a blend is used. Most manufacturers use a
mixture of vegetable oils.
0015 The fat source must also provide the essential fatty
acids linoleic (C18:2, o -6) and a-linolenic acid
(C18:3, o-3). Current research suggests that a balance
between these two fatty acids is necessary, as excess
linoleic acid suppresses the formation of a-linolenic
acid derivatives. A ratio of 5:1 of o-6:o-3, as occurs
in breast milk, is being suggested. However, there is a
need for more short- and long-term studies before the
optimum ratio and its effects on growth are evalu-
ated. Not all infant formulas provide a ratio of 5:1.
0016 Linoleic and a-linolenic acid are the precursors
of the very-long-chain (C20–C22) polyunsaturated
fatty acids (LCPUFA), arachidonic and docosahexa-
enoic acid. LCPUFA are involved in the neural and
vascular development of the fetus and neonate and
are present in human milk. Recently, there has been
much interest in the possible benefits of the addition
of LCPUFA to infant formulas. A recent systematic
review concluded that o-3 LCPUFA increases the
early visual maturation in preterm infants, but no
long-term benefit has been shown for preterm infants
receiving formula supplemented with LCPUFA. How-
ever, another systematic review prepared by the same
author, examining the effect of LCPUFA supplemen-
tation in term infants, concluded that there is little
evidence that it confers any benefit on visual or cog-
nitive development. Currently, some, but not all,
infant formulas are supplemented with LCPUFA.
0017 Nucleotides, a component of the nonprotein nitro-
gen in human milk, may be important for normal
immune function. Nucleotides can also be synthe-
sized endogenously. Nucleotide nitrogen accounts
for 0.1–0.15% of the total nitrogen content of
human milk, but is present in much smaller concen-
trations in cows’ milk-based formulas. Supplemen-
tion of infant formulas with nucleotides seems to be
beneficial in clinical trials, although further research
is needed before routine nucleotide supplementation
of infant formulas can be considered.
0018 Since 1984, a further range of formulas have been
manufactured known as ‘follow-on’ milks. These are
based on cows’ milk and are intended for use from 6
months of age in the UK, as part of mixed feeding.
They are not suitable as a replacement for either
breast milk or infant formulas before this age.
0019 ‘Follow-on’ milks have a higher protein and iron
content than infant formulas, but the energy density is
similar. The main 1995 compositional guidelines for
infant and ‘follow-on’ formulas set by the European
Commission Directives 91/321/EEC and 92/52/EEC
are shown in Table 1. The iron, calcium, and sodium
contents are higher than in infant formulas. Gener-
ally, all brands are supplemented with the full range
of vitamins and minerals.
0020Soya infant formulas are manufactured from soya
protein isolate and used for infants on cows’ milk-free
diet. Their carbohydrate source is a glucose polymer,
and the protein is derived from soy. They are supple-
mented with methionine, carnitine, minerals, vita-
mins, and trace elements, so that the available
nutrients are similar to those in human milk (Table 1).
Production
0021Advances in food technology since the early 1960s
have enabled manufacturers to produce infant formu-
las that are in line with present scientific knowledge
about infants’ nutritional requirements.
0022Infant formulas are typically composed of the
following: skimmed milk, demineralized whey (in
whey-dominant formulas only), a carbohydrate
source, fat blend, and vitamins and minerals. Each
raw material undergoes stringent quality-control
checks on arrival at the factory and throughout
all stages of manufacture. These tests are for nutri-
tional composition, purity, microbiological safety,
and physical properties. The manufacturing process
and the cleaning of the manufacturing plant are
partially or fully automated.
0023Production methods vary, but all aim to blend the
raw ingredients together to produce a safe, homoge-
neous, and stable powder or liquid. A typical example
of an infant formula manufacture is as follows:
0024Pasteurized skimmed milk is bought in as liquid or
powder. On arrival, the liquid milk is usually repas-
teurized by heating to 72
C for 15 s, which destroys
about 90% of all microorganisms present. Through-
out the manufacturing process, the product is repas-
teurized several times. Whey is purchased in a
demineralized form or is demineralized on site. The
technique of demineralization, which was perfected
in the 1960s, was a major advance in infant formula
production and is performed by electrodialysis,
ultrafiltration, or ion exchange. The repasteurized
skimmed milk and demineralized whey are mixed
with the carbohydrate source, vitamin premix, min-
erals, and the fat blend. The minerals required will
vary, depending on their concentration in other raw
materials. The fat-soluble vitamins are usually added
to the fat prior to this process.
0025The bulk ingredients usually undergo centrifugal
clarification, to remove small particle matter, and
INFANT FOODS/Milk Formulas 3273